Search

everythinglearnresearchcommunity

for

Search:↓

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Post-steroid panniculitis is now rare because doctors taper steroids more carefully.

Some pediatric Ewing's sarcoma patients may experience permanent hair loss after chemotherapy, and treatments might not fully restore hair.

Imatinib can cause hair loss due to lichen planopilaris.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Early and accurate diagnosis of primary vitreoretinal lymphoma is crucial to prevent serious complications.

Bortezomib chemotherapy can cause temporary skin rashes.

A man with four autoimmune diseases suggests a new category for multiple autoimmune syndrome.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

The malignant pilomatricoma showed strong epithelial keratin expression, suggesting it may not calcify.

Targeted cancer therapies often cause serious skin problems that need careful management.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Cats likely have a reactive skin condition, while dogs may have a more complex, possibly cancerous one.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

Ancient immune and signaling pathways still regulate blood cell development.

Hair loss can occur when stomach cancer spreads to the scalp.